UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses

Neuroscience, 2007-11, Vol.149 (3), p.706-714

2007

Volltextzugriff (PDF)

The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

Neuropharmacology, 2000-03, Vol.39 (4), p.652-663

2000

Volltextzugriff (PDF)

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

Neuropharmacology, 1996, Vol.35 (8), p.1121-1129

1996

Volltextzugriff (PDF)

Tumour-promoting phorbol esters inhibit agonist-induced phosphatidate formation and Ca 2+ flux in human platelets

FEBS letters, 1985-01, Vol.180 (2), p.160-164

1985

Volltextzugriff (PDF)

Substituted oxazole benzenesulfonamides as potent human β3 adrenergic receptor agonists

Bioorganic & medicinal chemistry letters, 2000-07, Vol.10 (14), p.1531-1534

2000

Volltextzugriff (PDF)

Platelet-activating factor and structurally related ether lipids: edited by J. Benveniste and B. Arnoux, Elsevier Science Publishers, 1983. $73.00, Dfl. 190 (xviii + 370 pages) ISBN 0 444 80552 4

Trends in pharmacological sciences (Regular ed.), 1984, Vol.5, p.402-403

MacIntyre, D.E.

1984

Volltextzugriff (PDF)

Platelet-activating factor and structurally related ether lipids

Trends in pharmacological sciences (Regular ed.), 1984-01, Vol.5, p.402-403

MacIntyre, D.E.

1984

Volltextzugriff (PDF)

3-Benzyloxy-2-phenylpiperidine NK1 antagonists : The influence of alpha methyl substitution

Bioorganic & medicinal chemistry letters, 1997-12, Vol.7 (23), p.2959-2962

1997

Volltextzugriff (PDF)

The novel NK 1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

Neuropharmacology, 2000, Vol.39 (4), p.652-663

2000

Volltextzugriff (PDF)

Substituted oxazole benzenesulfonamides as potent human β 3 adrenergic receptor agonists

Bioorganic & medicinal chemistry letters, 2000, Vol.10 (14), p.1531-1534

2000

Volltextzugriff (PDF)

Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase C

FEBS letters, 1985-09, Vol.188 (2), p.383-388

1985

Volltextzugriff (PDF)

The Role of PI Turnover in Txa2 -Induced Platelet Activation :Effects of TxA2 Antagonists

European heart journal, 1983-04, Vol.4 (suppl-B), p.4-4

1983

Volltextzugriff (PDF)

The role of CD 18 in IL‐8 induced dermal and synovial inflammation

British journal of pharmacology, 1992-06, Vol.106 (2), p.287-294

1992

Volltextzugriff (PDF)

3-Benzyloxy-2-phenylpiperidine NK 1 antagonists: the influence of alpha methyl substitution

Bioorganic & medicinal chemistry letters, 1997, Vol.7 (23), p.2959-2962

1997

Volltextzugriff (PDF)

Tachykinin NK 1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

Neuropharmacology, 1996, Vol.35 (8), p.1121-1129

1996

Volltextzugriff (PDF)

Evidence that circulating 6keto prostaglandin E 1 causes the platelet defect of Bartter's syndrome

Prostaglandins, leukotrienes and essential fatty acids, 1990, Vol.41 (4), p.251-258

1990

Volltextzugriff (PDF)

Evidence that circulating 6keto prostaglandin E1 causes the platelet defect of Bartter's syndrome

Prostaglandins, leukotrienes and essential fatty acids, 1990-12, Vol.41 (4), p.251-258

1990

Volltextzugriff (PDF)

Platelet products and vascular PGI 2 production

Prostaglandins leukotrienes and medicine, 1983, Vol.10 (1), p.73-81

1983

Volltextzugriff (PDF)

Tumour‐promoting phorbol esters inhibit agonist‐induced phosphatidate formation and Ca2+ flux in human platelets

FEBS letters, 1985-01, Vol.180 (2), p.160-164

1985

Volltextzugriff (PDF)

To the Editor

Blood, 1982-01, Vol.59 (1), p.203-204

1982

Volltextzugriff (PDF)

Platelet aggregation by basement membrane - associated collagens

Thrombosis research, 1980-01, Vol.18 (3), p.375-388

1980

Volltextzugriff (PDF)

Discrimination between platelet prostaglandin receptors with a specific antagonist of bisenoic prostaglandins

Thrombosis research, 1977-12, Vol.11 (6), p.705-713

1977

Volltextzugriff (PDF)

Antagonism of human platelet responses to stimulatory and inhibitory prostaglandins

Progress in lipid research, 1981, Vol.20, p.453-459

1981

Volltextzugriff (PDF)

PROSTACYCLIN OVERPRODUCTION IN BARTTER'S SYNDROME

The Lancet (British edition), 1979-12, Vol.314 (8153), p.1196-1197

1979

Volltextzugriff (PDF)

Effect of platelet activity of inhibition of adenylate cyclase

Thrombosis research, 1978-12, Vol.13 (6), p.1089-1101

1978

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses

The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

Tumour-promoting phorbol esters inhibit agonist-induced phosphatidate formation and Ca 2+ flux in human platelets

Substituted oxazole benzenesulfonamides as potent human β3 adrenergic receptor agonists

Platelet-activating factor and structurally related ether lipids: edited by J. Benveniste and B. Arnoux, Elsevier Science Publishers, 1983. $73.00, Dfl. 190 (xviii + 370 pages) ISBN 0 444 80552 4

Platelet-activating factor and structurally related ether lipids

3-Benzyloxy-2-phenylpiperidine NK1 antagonists : The influence of alpha methyl substitution

The novel NK 1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

Substituted oxazole benzenesulfonamides as potent human β 3 adrenergic receptor agonists

Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase C

The Role of PI Turnover in Txa2 -Induced Platelet Activation :Effects of TxA2 Antagonists

The role of CD 18 in IL‐8 induced dermal and synovial inflammation

3-Benzyloxy-2-phenylpiperidine NK 1 antagonists: the influence of alpha methyl substitution

Tachykinin NK 1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

Evidence that circulating 6keto prostaglandin E 1 causes the platelet defect of Bartter's syndrome

Evidence that circulating 6keto prostaglandin E1 causes the platelet defect of Bartter's syndrome

Platelet products and vascular PGI 2 production

Tumour‐promoting phorbol esters inhibit agonist‐induced phosphatidate formation and Ca2+ flux in human platelets

To the Editor

Platelet aggregation by basement membrane - associated collagens

Discrimination between platelet prostaglandin receptors with a specific antagonist of bisenoic prostaglandins

Antagonism of human platelet responses to stimulatory and inhibitory prostaglandins

PROSTACYCLIN OVERPRODUCTION IN BARTTER'S SYNDROME

Effect of platelet activity of inhibition of adenylate cyclase

Suchergebnisse filtern